History & Research (303) 741-1181
THE SAME AND ONLY LASER FDA APPROVED FOR LIPOSUCTION SURGERY
First used to facilitate liposuction procedures, the Lipo-Laser by Erchonia was noted to improve liposuction through a preoperative treatment which caused fat cells to 'leak' their fatty material into the surrounding area. This liquefied fat was then removed using traditional surgical techniques. Interestingly, the procedure was quicker and easier for the surgeon, safer for the patient (less bleeding), caused less bruising and was noted to have a quicker and more comfortable recovery. It was postulated, however, that if the liquefied fat was left within the body, the body would reabsorb this material and excrete it--hence, non-surgical fat reduction and body-contouring was born. Recently-completed and soon-to-be-published research confirms that patients can lose inches without invasive surgery through a series of ZERONA treatments using the Lipo-Laser.
Non-invasive low level laser assisted therapy has been approved by the FDA when used in conjunction with liposuction. This treatment, when used without liposuction, is currently considered an “off-label” use of the device. The data from these studies is pending FDA approval (expected Spring 2009).
WHY THE ERCHONIA LOW-LEVEL LASER IS THE BEST AND WHY I CHOSE THIS BRAND?
There are high-power lasers, and there is the patented process of the Erchonia low-level laser. High-power lasers (which most of you are very familiar with) generate enough heat or thermal output to destroy tissue. On the other, hand low-level laser (cold) output has no thermal effect on the body’s tissue.
The cold laser effect serves to stimulate biological function. There are hundreds of published studies in medical journals that demonstrate the abilities of cold laser to treat many conditions such as acute and chronic pain, scar treatment, burn/skin treatment, acne treatment and pre- and post-operative treatment, without any negative side-effects.
RESEARCH
The scientific articles, announcements and news stories below detail the history of Zerona and the Lipo-Laser from its beginnings in liposuction, the discovery of the laser's mechanism of action, and it's evolution into the breakthrough non-surgical fat-reduction treatment today.
Dec 2008 - Full clinical trial results due to be presented at 4PM.
Jun 2008 - American Society for Lasers in Medicine & Surgery Lecture
Apr 2008 - Erchonia Study Results Released
Sep 2004 - FDA clearance of Erchonia EML Laser for Liposuction
Jan 2003 - Dermatology Times by Dr. Butterwick
Sep 2002 - Fat Liquefaction using Low Level Laser Therapy (Niera)
Sep 2002 - Fat Liquefaction using Low Level Laser Therapy -- full article (Niera)
Oct 2000 - World Congress on Liposuction (Niera) 2000
Recently, the preliminary results of the Independent Review Board-approved, double-blind, randomized, placebo-controlled, multi-site clinical trial on Zerona using Lipo-Laser were released at the American Society for Lasers in Medicine and Surgery Conference in April of 2008. The full results and details of the clinical trials were presented at a Special Session of the16th Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies this Winter in Las Vegas, Thursday December 11, 2008 at 4PM.
Study link: http://www.clinicaltrials.gov/ct2/show/record/NCT00738426
Click here for the Erchonia website (manufacturers of the Zerona lipoLASER)
First used to facilitate liposuction procedures, the Lipo-Laser by Erchonia was noted to improve liposuction through a preoperative treatment which caused fat cells to 'leak' their fatty material into the surrounding area. This liquefied fat was then removed using traditional surgical techniques. Interestingly, the procedure was quicker and easier for the surgeon, safer for the patient (less bleeding), caused less bruising and was noted to have a quicker and more comfortable recovery. It was postulated, however, that if the liquefied fat was left within the body, the body would reabsorb this material and excrete it--hence, non-surgical fat reduction and body-contouring was born. Recently-completed and soon-to-be-published research confirms that patients can lose inches without invasive surgery through a series of ZERONA treatments using the Lipo-Laser.
Non-invasive low level laser assisted therapy has been approved by the FDA when used in conjunction with liposuction. This treatment, when used without liposuction, is currently considered an “off-label” use of the device. The data from these studies is pending FDA approval (expected Spring 2009).
WHY THE ERCHONIA LOW-LEVEL LASER IS THE BEST AND WHY I CHOSE THIS BRAND?
There are high-power lasers, and there is the patented process of the Erchonia low-level laser. High-power lasers (which most of you are very familiar with) generate enough heat or thermal output to destroy tissue. On the other, hand low-level laser (cold) output has no thermal effect on the body’s tissue.
The cold laser effect serves to stimulate biological function. There are hundreds of published studies in medical journals that demonstrate the abilities of cold laser to treat many conditions such as acute and chronic pain, scar treatment, burn/skin treatment, acne treatment and pre- and post-operative treatment, without any negative side-effects.
RESEARCH
The scientific articles, announcements and news stories below detail the history of Zerona and the Lipo-Laser from its beginnings in liposuction, the discovery of the laser's mechanism of action, and it's evolution into the breakthrough non-surgical fat-reduction treatment today.
Dec 2008 - Full clinical trial results due to be presented at 4PM.
Jun 2008 - American Society for Lasers in Medicine & Surgery Lecture
Apr 2008 - Erchonia Study Results Released
Sep 2004 - FDA clearance of Erchonia EML Laser for Liposuction
Jan 2003 - Dermatology Times by Dr. Butterwick
Sep 2002 - Fat Liquefaction using Low Level Laser Therapy (Niera)
Sep 2002 - Fat Liquefaction using Low Level Laser Therapy -- full article (Niera)
Oct 2000 - World Congress on Liposuction (Niera) 2000
Recently, the preliminary results of the Independent Review Board-approved, double-blind, randomized, placebo-controlled, multi-site clinical trial on Zerona using Lipo-Laser were released at the American Society for Lasers in Medicine and Surgery Conference in April of 2008. The full results and details of the clinical trials were presented at a Special Session of the16th Annual World Congress on Anti-Aging Medicine and Regenerative Biomedical Technologies this Winter in Las Vegas, Thursday December 11, 2008 at 4PM.
Study link: http://www.clinicaltrials.gov/ct2/show/record/NCT00738426
Click here for the Erchonia website (manufacturers of the Zerona lipoLASER)
